Wayne S DeVeydt

CIK 1321392 · Chief Financial Officer · last filed 2026-09-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.34M

Companies

8

Total Filings

117

Lifetime Open-Market Net

-$78.96M

Filer Profile

Reported Address
1 HEALTH DRIVE
EDEN PRAIRIE, MN 55344
Related Filers
NISOURCE INC/DE — 8 joint filings, latest 2021-05-26
UNITEDHEALTH GROUP INC — 8 joint filings, latest 2026-09-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
UNH Chief Financial Officer 18,569 $379.09 $7.04M $0 7 2026-09-04
CENTENE CORP (CNTE) Delisted Director 19,523 $0 19 2025-07-02
SGRY Exec Chairman of the Board 105,203 $14.38 $1.51M -$9.79M 19 2025-03-25
NI Director 35,480 $41.41 $1.47M $0 7 2021-05-26
Myovant Sciences Ltd. (MYOV) Delisted Director $26.98 $0 2 2017-10-20
ANTX EVP & Chief Financial Officer 57,957 $5.41 $313.5K -$1.00M 3 2016-03-04
Elevance Health, Inc. (ANTM) Delisted EVP & Chief Financial Officer 82,126 $482.58 $39.63M -$18.37M 3 2015-04-08
Elevance Health, Inc. (WLP) Delisted EVP & Chief Financial Officer 128,442 -$49.80M 27 2014-11-12

Recent Filings · Page 2 of 12

117 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-10-16 SGRY Notice (144) −52,946 -$1.13M EDGAR
2025-10-15 SGRY Notice (144) −25,076 -$526.9K EDGAR
2025-10-15 CNC Notice (144) −5,489 -$196.7K EDGAR
2025-10-14 SGRY Notice (144) −25,000 -$513.6K EDGAR
2025-10-09 SGRY Notice (144) −3,145 -$65.3K EDGAR
2025-10-08 SGRY Notice (144) −25,000 -$513.2K EDGAR
2025-09-29 SGRY Notice (144) −18,134 -$399.8K EDGAR
2025-09-26 SGRY Notice (144) −5,627 -$123.8K EDGAR
2025-09-25 UNH Grant (A) +66 $0 EDGAR
2025-09-23 SGRY Notice (144) −25,000 -$550.4K EDGAR
Showing 1120 of 117
Page 2 of 12
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.